Liaoning Cheng Da Co., Ltd. (SHA:600739)

China · Delayed Price · Currency is CNY

12.17

+0.08 (0.66%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biopharmaceutical	1.68B	-						1.28B	1.03B	943.42M
Biopharmaceutical Growth	-	-						23.93%	9.14%	0.68%
Energy Development	18.82M	-						90.41M	52.26M	123.11M
Energy Development Growth	-	-						73.00%	-57.55%	-54.28%
Stock Headquarters	9.68M	-						64.58M	65.58M	38.76M
Stock Headquarters Growth	-	-						-1.53%	69.18%	215.68%
Domestic and Foreign Trade	9.58B	-						9.50B	4.58B	5.30B
Domestic and Foreign Trade Growth	-	-						107.58%	-13.60%	-2.54%
Offset Of Business Segment	-3.62M	-						-57.46M	-58.85M	-30.98M
Pharmaceutical Chain	-	-						3.11B	3.07B	2.76B
Pharmaceutical Chain Growth	-	-						1.30%	11.52%	6.49%
Total	11.28B	-						13.99B	8.74B	9.13B
Total Growth	-	-						60.06%	-4.26%	-1.05%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Mainland China	9.81B	-
Asia (Excl. Mainland China)	769.66M	-
Europe	31.54M	-
Americas	613.67M	-
Africa	59.76M	-
Oceania	783.69K	-
Total	11.29B	-

Source: S&P Global Market Intelligence.